|
US2009208540A1
|
|
Implantable device for the delivery of naltrexone and methods of use thereof
|
|
WO2009073517A2
|
|
Intravesical compositions with valrubicin for the treatment of bladder cancer
|
|
US2007099988A1
|
|
Anti-emetic uses of (3r, 4r)-delta8-tetrahydrocannabinol-11-oic acids
|
|
WO2007047010A2
|
|
Anti-emetic uses of cannabinoid analogs
|
|
US2006217405A1
|
|
Interstitial cystitis treatment
|
|
CN101193626A
|
|
Controlled release formulations of octreotide
|
|
US2006128794A1
|
|
Treatment of interstitial cystitis using (6aR,10aR)-delta8-tetrahydrocannabinol-11-OIC acids
|
|
US2006128738A1
|
|
Treatment of interstitial cystitis using cannabinoid analogs
|
|
US2005232983A1
|
|
Transdermal patch
|
|
CA2523567A1
|
|
Method for promoting uninterrupted sleep by administration of trospium chloride
|
|
WO03026651A1
|
|
Method of inhibiting the production and/or effects of intestinal pro-inflammatory cytokines, prostaglandins and others
|
|
US6974835B2
|
|
Methods for decreasing cell proliferation based on (3r,4r)-Δ8-tetrahydrocannabinol-11-oic acids
|
|
HK1029925A1
|
|
Cannabinol-11-oic acid derivatives useful as antiinflammatory agents and analgesics
|
|
US6855721B1
|
|
Methods and compositions for alleviating stuttering
|
|
EP1067911A1
|
|
Hydrogel compositions useful for the sustained release of macromolecules and methods of making same
|
